← Leaderboards
Ambra Pozzi
Veterans Health Administration
$8,402,682
Attributed
$9,383,403
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,308,403 · 12
VA$0 · 2
By mechanism
R01$7,808,003 · 5
P30$5,925,000 · 2
P01$1,276,739 · 1
R43$228,661 · 1
R13$70,000 · 2
P50$0 · 1
Top collaborators
- Corina Marilena Borza5 shared
- Raymond Harris5 shared
- Celia Jenkinson1 shared
Others in their field
Top investigators on “Receptor”
- Barton F Haynes · Duke University$182,835,224
- James C. Paulson · Scripps Research Institute$84,068,192
- Asrar B. Malik · University Of Illinois At Chicago$55,280,031
- Anthony O Caggiano · Cognition Therapeutics, Inc.$49,563,751
- Robert J Coffey · Vanderbilt University$48,115,270
- Robert H Vonderheide · University Of Pennsylvania$48,030,034
Research focus
ReceptorIn VitroMediatingHomeostasisBaseKidneyFibrosisCellsIntegrinsMolecularPathway InteractionsPlayProductionCollagenPreventInjurySignal TransductionIn VivoLigandsRegulationChronic Kidney FailureExtracellular MatrixEnd Stage Renal FailureInsight
Grant awards (62)
Molecular Mechanisms of Kidney Fibrosis$0
I01 · FY2025 · VA · contact PI
BLR&D Merit Review Research Career Scientist (RCS) Award (IK6)$0
IK6 · FY2025 · VA · contact PI
Molecular Mechanisms of Kidney Fibrosis$0
I01 · FY2024 · VA · contact PI
BLR&D Merit Review Research Career Scientist (RCS) Award (IK6)$0
IK6 · FY2024 · VA · contact PI
ASMB 2023: Tissue, Matrix, and Pathobiology$55,000
R13 · FY2023 · AR · contact PI
2023 Fibronectin, Integrins and Related Molecules Gordon Research Conference and Gordon Research Seminar$15,000
R13 · FY2023 · AR · contact PI
Molecular Mechanisms of Kidney Fibrosis$0
I01 · FY2023 · VA · contact PI
BLR&D Merit Review Research Career Scientist (RCS) Award (IK6)$0
IK6 · FY2023 · VA · contact PI
Matrix receptors in chronic kidney disease$339,433
R01 · FY2022 · DK · contact PI
BLR&D Merit Review Research Career Scientist (RCS) Award (IK6)$0
IK6 · FY2022 · VA · contact PI
Vanderbilt O'Brien Kidney Center$1,185,000
P30 · FY2021 · DK
Matrix receptors in chronic kidney disease$339,433
R01 · FY2021 · DK · contact PI
BLR&D Merit Review Research Career Scientist (RCS) Award (IK6)$0
IK6 · FY2021 · VA · contact PI
Role of Collagen Binding Receptors in Glomerulosclerosis$0
I01 · FY2021 · VA · contact PI
Vanderbilt O'Brien Kidney Center$1,185,000
P30 · FY2020 · DK
Matrix receptors in chronic kidney disease$339,433
R01 · FY2020 · DK · contact PI
Role of Collagen Binding Receptors in Glomerulosclerosis$0
I01 · FY2020 · VA · contact PI
BLR&D Merit Review Research Career Scientist (RCS) Award (IK6)$0
IK6 · FY2020 · VA · contact PI
Vanderbilt O'Brien Kidney Center$1,185,000
P30 · FY2019 · DK
Matrix receptors in chronic kidney disease$345,283
R01 · FY2019 · DK · contact PI
Role of Collagen Binding Receptors in Glomerulosclerosis$0
I01 · FY2019 · VA · contact PI
Vanderbilt O'Brien Kidney Center$1,185,000
P30 · FY2018 · DK
Matrix receptors in chronic kidney disease$369,199
R01 · FY2018 · DK · contact PI
Role of Collagen Binding Receptors in Glomerulosclerosis$0
I01 · FY2018 · VA · contact PI
Vanderbilt O'Brien Kidney Center$1,185,000
P30 · FY2017 · DK
The P450 Epoxygenases as Pro-Oncogenic Enzymes$394,456
R01 · FY2016 · CA · contact PI
Integrin/TGF-beta Axis in Tubulointerstitial Fibrosis$238,417
R01 · FY2016 · DK · contact PI
Integrin/TGF-beta Axis in Tubulointerstitial Fibrosis$103,901
R01 · FY2016 · DK · contact PI
Role of Collagen Binding Receptors in Glomerulosclerosis$0
I01 · FY2016 · VA · contact PI
Integrin/TGF-beta Axis in Tubulointerstitial Fibrosis$339,300
R01 · FY2015 · DK · contact PI
The P450 Epoxygenases as Pro-Oncogenic Enzymes$244,897
R01 · FY2015 · CA · contact PI
Novel integrin inhibitors for kidney fibrosis$228,661
R43 · FY2015 · DK
The P450 Epoxygenases as Pro-Oncogenic Enzymes$162,333
R01 · FY2015 · CA · contact PI
Role of Collagen Binding Receptors in Glomerulosclerosis$0
I01 · FY2015 · VA · contact PI
The P450 Epoxygenases as Pro-Oncogenic Enzymes$371,804
R01 · FY2014 · CA · contact PI
Integrin/TGF-beta Axis in Tubulointerstitial Fibrosis$339,300
R01 · FY2014 · DK · contact PI
Role of Collagen Binding Receptors in Glomerulosclerosis$0
I01 · FY2014 · VA · contact PI
The P450 Epoxygenases as Pro-Oncogenic Enzymes$381,322
R01 · FY2013 · CA · contact PI
Integrin/TGF-beta Axis in Tubulointerstitial Fibrosis$339,300
R01 · FY2013 · DK · contact PI
Role of Collagen Binding Receptors in Glomerulosclerosis$0
I01 · FY2013 · VA · contact PI
The P450 Epoxygenases as Pro-Oncogenic Enzymes$336,781
R01 · FY2012 · CA · contact PI
THE ROLE OF INTEGRINS a1B1 and a2B2 IN COLLAGEN IV HOMEOSTASIS$258,300
P01 · FY2012 · DK · contact PI
THE ROLE OF INTEGRINS a1B1 and a2B2 IN COLLAGEN IV HOMEOSTASIS$258,297
P01 · FY2011 · DK · contact PI
THE ROLE OF INTEGRINS a1B1 and a2B2 IN COLLAGEN IV HOMEOSTASIS$260,906
P01 · FY2010 · DK · contact PI
THE ROLE OF INTEGRINS a1B1 and a2B2 IN COLLAGEN IV HOMEOSTASIS$253,306
P01 · FY2009 · DK · contact PI
Role of Cyclooxygenase stimulated Neovascularization in Diabetic Nephropathy$249,611
R01 · FY2008 · DK · contact PI
THE ROLE OF INTEGRINS a1B1 and a2B2 IN COLLAGEN IV HOMEOSTASIS$245,930
P01 · FY2008 · DK · contact PI
Control of Tumor Growth by the MMP/Angiostatin Pathway$318,565
R01 · FY2007 · CA · contact PI
Role of Cyclooxygenase stimulated Neovascularization in Diabetic Nephropathy$254,706
R01 · FY2007 · DK · contact PI
Control of Tumor Growth by the MMP/Angiostatin Pathway$43,413
R01 · FY2007 · CA · contact PI
Control of Tumor Growth by the MMP/Angiostatin Pathway$328,079
R01 · FY2006 · CA · contact PI
Role of Cyclooxygenase stimulated Neovascularization in Diabetic Nephropathy$224,168
R01 · FY2006 · DK · contact PI
Control of Tumor Growth by the MMP/Angiostatin Pathway$43,413
R01 · FY2006 · CA · contact PI
Control of Tumor Growth by the MMP/Angiostatin Pathway$335,975
R01 · FY2005 · CA
Role of Cyclooxygenase stimulated Neovascularization in Diabetic Nephropathy$228,125
R01 · FY2005 · DK
Control of Tumor Growth by the MMP/Angiostatin Pathway$43,413
R01 · FY2005 · CA
Control of Tumor Growth by the MMP/Angiostatin Pathway$335,975
R01 · FY2004 · CA
Control of Tumor Growth by the MMP/Angiostatin Pathway$54,662
R01 · FY2004 · CA
Control of Tumor Growth by the MMP/Angiostatin Pathway$335,975
R01 · FY2003 · CA
Control of Tumor Growth by the MMP/Angiostatin Pathway$27,331
R01 · FY2003 · CA
PILOT--ROLE OF INTEGRIN ALPHA 1 BETA 1 IN GLOMERULOSCLER$0
P50 · FY2002 · DK
Integrin alpha1 null mice as genetic model to study skin disease$0
P30 · FY2002 · AR